• Edwards Lifesciences CEO Bernard J. Zovighian reported a gift disposal of 320 common shares on July 27, 2026.
• The shares were transferred at $0, leaving him with 98,845 shares held directly.
• A trust acquired 320 shares via the gift, then sold 2,921 shares at $83.93, ending with 8,916 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Edwards Lifesciences Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001225208-26-006743), on July 27, 2026, and is solely responsible for the information contained therein.